History of the company
Our company was founded in 1996 and we entered the hospital medication supply market in 2014. Based on the long term contracts, we represent important European drugs producers from Latvia, Romania and Italy. We value our customers, we put their needs on the first place; our representatives are professionals with commitment to laws and ethics.
We are offering a wide selection of high quality genetics for multitude therapeutic applications for the hospital medication market. We are predominantly focusing on the analgesics, anaesthetics, antibiotics, and gynaecologicals drugs specific medications. We are investing our resources into production our own generics.
What are generics?
Generics are drugs with the same composition and the treatment effect as the original drug. They offer a therapeutic alternative to against the original drugs. Generics are produced in the same dosage and form as their original alternative, despite not being produced by the original producers.
Thanks to the lack of the development cost (they can be reproduced due to the patent expiration), they can be offered at a lower price compared to the originals. Neither is required to fund the expensive toxicologic and clinical studies as they were already provided by the original producer. The wide spread knowledge of the effectiveness of the original drug does not require the costly marketing and advertisement.
However, it is necessary to prove to the regulatory bodies that the drugs are as safe and effective as the original drugs.